Team
Maha Ayyoub

T2i :

Anti-tumour immunity and immunotherapy

The specificities
of our research axis

Tumour antigen-specific T cells

T cell depletion

Immune checkpoint inhibitor immunotherapy

Anti-cancer vaccines

Clinical trials

Pre-clinical orthotopic models

Genomics

Trancriptomics

Research
projects

THE TEAM’S
FOCUS

Live Feed

Stop renaming effector T cells just cause you found some of them express some different genes in your 10x data. It’s confusing everyone. They are just effector T cells. Not CD8+GZMB+ cells which also express Interferon genes and KIRS (CD8GINFKIR)

Load More...

Scientific production

PUBLICATIONS 2022
Angeles, Martina Aida, Alicia Hernández, Asunción Pérez-Benavente, Bastien Cabarrou, Emanuela Spagnolo, Agnieszka Rychlik, Amel Daboussi, et al. “The Effect of Major Postoperative Complications on Recurrence and Long-Term Survival after Cytoreductive Surgery for Ovarian Cancer.” Gynecologic Oncology, May 11, 2022, S0090-8258(22)00278-5. https://doi.org/10.1016/j.ygyno.2022.05.002.
Daix, Manon, Carlos Martinez Gomez, Martina Aida Angeles, Stéphanie Tock, Laurence Gladieff, Erwan Gabiache, Eliane Mery, Alejandra Martinez, David Cibula, and Gwénaël Ferron. “Extended Pelvic Resection for Gynecological Malignancies: A Review of out-of-the-Box Surgery.” Gynecologic Oncology, March 21, 2022, S0090-8258(22)00174-3. https://doi.org/10.1016/j.ygyno.2022.03.002.
Daix, Manon, Martina Aida Angeles, Hélène Leray, Kelig Vergriete, Alejandra Martinez, and Gwenael Ferron. “Anterior Pelvic Exenteration and Laterally Extended Pelvic Resection: A Step by Step Procedure.” International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 32, no. 1 (January 2022): 107–8. https://doi.org/10.1136/ijgc-2021-003047.
PUBLICATIONS 2021
Angeles, Martina Aida, Hélène Leray, Federico Migliorelli, Manon Daix, Alejandra Martinez, and Gwenael Ferron. “Surgical Approach of the Left Upper Quadrant for Ovarian Cancer in 10 Steps.” International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 31, no. 11 (November 2021): 1488–89. https://doi.org/10.1136/ijgc-2021-002963.
Cerapio, Juan-Pablo, Marion Perrier, Camille-Charlotte Balança, Pauline Gravelle, Fréderic Pont, Christel Devaud, Don-Marc Franchini, et al. “Phased Differentiation of Γδ T and T CD8 Tumor-Infiltrating Lymphocytes Revealed by Single-Cell Transcriptomics of Human Cancers.” Oncoimmunology 10, no. 1 (2021): 1939518. https://doi.org/10.1080/2162402X.2021.1939518.
Khalifa, Jonathan, Julien Mazieres, Carlos Gomez-Roca, Maha Ayyoub, and Elizabeth Cohen-Jonathan Moyal. “Radiotherapy in the Era of Immunotherapy With a Focus on Non-Small-Cell Lung Cancer: Time to Revisit Ancient Dogmas?” Frontiers in Oncology 11 (2021): 662236. https://doi.org/10.3389/fonc.2021.662236.
PUBLICATIONS 2020
Balança, Camille-Charlotte, Anna Salvioni, Clara-Maria Scarlata, Marie Michelas, Carlos Martinez-Gomez, Carlos Gomez-Roca, Victor Sarradin, et al. “PD-1 Blockade Restores Helper Activity of Tumor-Infiltrating Exhausted PD-1hiCD39+ CD4 T Cells.” JCI Insight, December 17, 2020. https://doi.org/10.1172/jci.insight.142513.
Montfort, Anne, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pages, Pascale Olivier, et al. “Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase 1b Clinical Trial.” Clinical Cancer Research, December 3, 2020, clincanres.3449.2020. https://doi.org/10.1158/1078-0432.CCR-20-3449.
Weulersse, Marianne, Assia Asrir, Andrea C. Pichler, Lea Lemaitre, Matthias Braun, Nadege Carrie, Marie-Veronique Joubert, et al. “Eomes-Dependent Loss of the Co-Activating Receptor CD226 Restrains CD8(+) T Cell Anti-Tumor Functions and Limits the Efficacy of Cancer Immunotherapy.” Immunity 53, no. 4 (October 13, 2020): 824-839.e10. https://doi.org/10.1016/j.immuni.2020.09.006.
Fluckiger, Aurélie, Romain Daillère, Mohamed Sassi, Barbara Susanne Sixt, Peng Liu, Friedemann Loos, Corentin Richard, et al. “Cross-Reactivity between Tumor MHC Class I-Restricted Antigens and an Enterococcal Bacteriophage.” Science (New York, N.Y.) 369, no. 6506 (August 21, 2020): 936–42. https://doi.org/10.1126/science.aax0701.
Trimaglio, Giulia, Anne-Françoise Tilkin-Mariamé, Virginie Feliu, Françoise Lauzéral-Vizcaino, Marie Tosolini, Carine Valle, Maha Ayyoub, et al. “Colon-Specific Immune Microenvironment Regulates Cancer Progression versus Rejection.” Oncoimmunology 9, no. 1 (July 12, 2020): 1790125. https://doi.org/10.1080/2162402X.2020.1790125.
Martinez, Alejandra, Jean-Pierre Delord, Maha Ayyoub, and Christel Devaud. “Preclinical and Clinical Immunotherapeutic Strategies in Epithelial Ovarian Cancer.” Cancers 12, no. 7 (July 2, 2020): 1761. https://doi.org/10.3390/cancers12071761.
Balança, Camille-Charlotte, Clara-Maria Scarlata, Marie Michelas, Christel Devaud, Victor Sarradin, Camille Franchet, Carlos Martinez Gomez, et al. “Dual Relief of T-Lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies.” Cancer Immunology Research 8, no. 7 (July 2020): 869–82. https://doi.org/10.1158/2326-6066.CIR-19-0855.
Pont, Frédéric, Marie Tosolini, Qing Gao, Marion Perrier, Miguel Madrid-Mencía, Tse Shun Huang, Pierre Neuvial, Maha Ayyoub, Kristopher Nazor, and Jean-Jacques Fournié. “Single-Cell Virtual Cytometer Allows User-Friendly and Versatile Analysis and Visualization of Multimodal Single Cell RNAseq Datasets.” NAR Genomics and Bioinformatics 2, no. 2 (June 1, 2020): lqaa025. https://doi.org/10.1093/nargab/lqaa025.
Prat, Mélissa, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Godefroy Jacquemin, Mouna Chirine Rahabi, et al. “Circulating CD14 high CD16 low Intermediate Blood Monocytes as a Biomarker of Ascites Immune Status and Ovarian Cancer Progression.” Journal for ImmunoTherapy of Cancer 8, no. 1 (2020): e000472. https://doi.org/10.1136/jitc-2019-000472.
PUBLICATIONS 2019
Montfort, Anne, Carine Dufau, Céline Colacios, Nathalie Andrieu-Abadie, Thierry Levade, Thomas Filleron, Jean-Pierre Delord, Maha Ayyoub, Nicolas Meyer, and Bruno Ségui. “Anti-TNF, a Magic Bullet in Cancer Immunotherapy?” Journal for Immunotherapy of Cancer 7, no. 1 (November 14, 2019): 303. https://doi.org/10.1186/s40425-019-0802-y.
Franchini, Don-Marc, Olivia Lanvin, Marie Tosolini, Emilie Patras de Campaigno, Anne Cammas, Sarah Péricart, Clara-Maria Scarlata, et al. “Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells.” Cell Reports 26, no. 1 (January 2, 2019): 94-107.e7. https://doi.org/10.1016/j.celrep.2018.12.014.

LES MEMBRES DE L’ÉQUIPE

Jean-Pierre Delord
Hospitalo-Universitaire / University teacher hospital practitioner
Françoise Lauzeral-Vizcaino
Ingénieur de laboratoire / laboratory engineer
Clara-Maria Scarlata
Ingénieur de laboratoire / laboratory engineer
Anna Salvioni
Chercheur Post-Doctorant / Post-Doc researcher
Victor Sarradin
Doctorant / PhD student
Célia Ramade
Doctorant / PhD student
Sylvie Giuriato
Chercheur statutaire / permanent scientist
Noémie Thébault
Ingénieur de laboratoire / laboratory engineer

Partnerships & Funding

Centre de Recherches en Cancérologie de Toulouse

Centre de Recherches en Cancérologie de Toulouse (Oncopole)

Toulouse – FR

Nous contacter

05 82 74 15 75

Envie de rejoindre
L’équipe du CRCT ?

Pin It on Pinterest